Market open
Globus Medical/$GMED
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Globus Medical
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.
Ticker
$GMED
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
5,000
Website
Globus Medical Metrics
BasicAdvanced
$11B
125.30
$0.67
1.19
-
Price and volume
Market cap
$11B
Beta
1.19
52-week high
$94.93
52-week low
$49.33
Average daily volume
1.2M
Financial strength
Current ratio
2.514
Quick ratio
1.574
Long term debt to equity
2.14
Total debt to equity
13.179
Interest coverage (TTM)
52.08%
Management effectiveness
Return on assets (TTM)
4.73%
Return on equity (TTM)
2.22%
Valuation
Price to earnings (TTM)
125.304
Price to revenue (TTM)
4.626
Price to book
2.81
Price to tangible book (TTM)
6.38
Price to free cash flow (TTM)
39.033
Growth
Revenue change (TTM)
102.10%
Earnings per share change (TTM)
-54.17%
3-year revenue growth (CAGR)
38.08%
3-year earnings per share growth (CAGR)
-28.25%
What the Analysts think about Globus Medical
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Globus Medical stock.
Globus Medical Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Globus Medical Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Globus Medical News
AllArticlesVideos
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
GlobeNewsWire·6 days ago
Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
GlobeNewsWire·2 weeks ago
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Globus Medical stock?
Globus Medical (GMED) has a market cap of $11B as of February 12, 2025.
What is the P/E ratio for Globus Medical stock?
The price to earnings (P/E) ratio for Globus Medical (GMED) stock is 125.3 as of February 12, 2025.
Does Globus Medical stock pay dividends?
No, Globus Medical (GMED) stock does not pay dividends to its shareholders as of February 12, 2025.
When is the next Globus Medical dividend payment date?
Globus Medical (GMED) stock does not pay dividends to its shareholders.
What is the beta indicator for Globus Medical?
Globus Medical (GMED) has a beta rating of 1.19. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.